Tiansheng Pharmaceutical Group Co., Ltd.

Equities

002872

CNE100002QC3

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
4.33 CNY -0.92% Intraday chart for Tiansheng Pharmaceutical Group Co., Ltd. +2.36% -15.59%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tiansheng Pharmaceutical Group Co., Ltd. Announces Executive Appointments CI
Tiansheng Pharmaceutical’s Paracetamol Tablet Passes Consistency Test MT
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tiansheng Pharmaceutical's Technology Center Named National Enterprise Technology Center MT
Tiansheng Pharmaceutical Unit Gets Regulatory Approval for Injection MT
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Chongqing Pharmaceutical CO., LTD. completed the acquisition of 51% stake in Chongqing Changsheng Medicine Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd.. CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Tiansheng Pharmaceutical Group Co., Ltd. Approves Election of Directors CI
An unknown buyer acquired 11% stake in Hubei Xianming Medical Apparatus and Instruments Co., Ltd. from Hubei Xianming Medical Apparatus and Instruments Co., Ltd. for CNY 5.1 million. CI
An unknown buyer acquired Chongqing Xinmei Pharmaceutical Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd. for CNY 0. CI
Chongqing Pharmaceutical CO., LTD. signed an equity transfer intention agreement to acquire 51% stake in Chongqing Changsheng Medicine Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd. for CNY 59.6 million. CI
Tiansheng Pharmaceutical Group Co., Ltd. cancelled the acquisition of Chongqing Dachuang Electrical Equipment Co., Ltd. from Chongqing Changlong Industrial Co., Ltd. CI
Tiansheng Pharmaceutical Group Co., Ltd. cancelled the acquisition of Chongqing Junyao Pharmaceutical Packing Products Co., Ltd. from Chen Yi and Feng Yi. CI
Tiansheng Pharmaceutical Group Co., Ltd. Announces 2017 Final Distribution Plan, Payable on August 22, 2018 CI
Tiansheng Pharmaceutical Approves the Cash Dividend for the Year 2017 CI
Tiansheng Pharmaceutical Proposes Final Dividend for the Year 2017 CI
Luzhou Tiansheng Pharmaceutical Co., Ltd. announced that it expects to receive CNY 150 million in funding from Tiansheng Pharmaceutical Group Co., Ltd. CI
Tiansheng Pharmaceutical Group Co., Ltd. agreed to acquire Chongqing Dachuang Electrical Equipment Co., Ltd. from Chongqing Changlong Industrial Co., Ltd. for CNY 31 million. CI
Tiansheng Pharmaceutical Group Co., Ltd. Forms Medical Appliances Joint Venture in Chongqing City, China CI
Chart Tiansheng Pharmaceutical Group Co., Ltd.
More charts
Tiansheng Pharmaceutical Group Co LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company's main products include pediatric lung cough particles, erythromycin enteric-coated capsules, silver ginseng Tongluo capsules, Salvia granules, Shugan Yi spleen granules, compound Ganoderma lucidum granules, Xiangdan injection, Injection, Qi and Diabetes tablets, liver capsule, Ling Jing capsule, lungs of nuclear paste, Shen Qi Yi lung pill, among others. The Company mainly distributes its products within domestic market.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 002872 Stock
  4. News Tiansheng Pharmaceutical Group Co., Ltd.
  5. Tiansheng Pharmaceutical's Technology Center Named National Enterprise Technology Center